- APHP-led IMPULSION project secures Coreline Soft as sole AI supplier - UGAP (France's central public procurement agency) registration completed,...
- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated ATLANTA,...
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it...
BANGKOK--(BUSINESS WIRE)--Taiwan’s "2025 Go Healthy with Taiwan" campaign has selected 21 semifinalists from 638 proposals across 55 countries, showcasing the...
The novel framework is designed to help accelerate clinical development through more efficient and informative early-stage trialsBOSTON--(BUSINESS WIRE)--Ontada®, a leader...
WHITTIER, Calif., Nov. 10, 2025 /PRNewswire/ -- The College of Healthcare Information Management Executives (CHIME) has recognized PIH Health and PIH...
The National Children's Cancer Society (NCCS), a leading nonprofit dedicated to supporting children with cancer, their families, and survivors, has...
For recipients across the country, this scholarship eases the financial burden of college while instilling hope, optimism, and confidence in...
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees...
COLOGNE, Germany, Nov. 10, 2025 /PRNewswire/ -- Under the subject "The Evolving Field of Cell and Gene Therapy", Cellex Cell...
A very unique multi-vertical health AI engine capable of early detection for mental health, wound infection, skin cancer, and disease...
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it...
First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting SEATTLE, WASHINGTON /...
OCALA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today detailed a...
Initial Investment of $1 Million Received from Hexstone Capital LLC Upon ClosingMELBOURNE, Australia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Propanc...
The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in operational...
PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company pioneering innovative cell therapies, today announced it will...